Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 24, 2022 at 09:48 am
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 2,586.06 million compared to CNY 2,334.62 million a year ago. Revenue was CNY 2,592.18 million compared to CNY 2,339.77 million a year ago. Net income was CNY 68.26 million compared to CNY 64.85 million a year ago. Basic earnings per share from continuing operations was CNY 0.44 compared to CNY 0.42 a year ago. Diluted earnings per share from continuing operations was CNY 0.44 compared to CNY 0.42 a year ago.